![A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation | SpringerLink A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00535-022-01862-y/MediaObjects/535_2022_1862_Fig2_HTML.png)
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation | SpringerLink
![European Crohn´s and Colitis Organisation - ECCO - OP24 Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study European Crohn´s and Colitis Organisation - ECCO - OP24 Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC21/abstracts/0000000270/0000012950/Images/table_1202103161523497011.jpg)
European Crohn´s and Colitis Organisation - ECCO - OP24 Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study
![Reliability, validity and critical appraisal of the cross-cultural adapted German version of the Mayo Elbow Performance Score (MEPS-G) | Journal of Orthopaedic Surgery and Research | Full Text Reliability, validity and critical appraisal of the cross-cultural adapted German version of the Mayo Elbow Performance Score (MEPS-G) | Journal of Orthopaedic Surgery and Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13018-022-03210-5/MediaObjects/13018_2022_3210_Fig1_HTML.png)
Reliability, validity and critical appraisal of the cross-cultural adapted German version of the Mayo Elbow Performance Score (MEPS-G) | Journal of Orthopaedic Surgery and Research | Full Text
![Table 6 from Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease | Semantic Scholar Table 6 from Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fd3fdc0460178d1575aec4f591e054fa0c8143c3/7-Table6-1.png)
Table 6 from Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease | Semantic Scholar
![How Should We be Assessing and Documenting Endoscopies in IBD: Incorporating Standard Scoring Systems into Patient Care Gary R Lichtenstein, MD Director, - ppt download How Should We be Assessing and Documenting Endoscopies in IBD: Incorporating Standard Scoring Systems into Patient Care Gary R Lichtenstein, MD Director, - ppt download](https://slideplayer.com/slide/4482866/14/images/17/Mayo+Scoring+System1+for+Assessment+of+UC+Activity.jpg)
How Should We be Assessing and Documenting Endoscopies in IBD: Incorporating Standard Scoring Systems into Patient Care Gary R Lichtenstein, MD Director, - ppt download
![A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis | SpringerLink A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10928-021-09789-2/MediaObjects/10928_2021_9789_Fig1_HTML.png)
A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis | SpringerLink
![Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment - ScienceDirect Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356522011090-fx1.jpg)
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment - ScienceDirect
![PDF) Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients PDF) Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients](https://i1.rgstatic.net/publication/349538020_Full_Partial_and_Modified_Permutations_of_the_Mayo_Score_Characterizing_Clinical_and_Patient-Reported_Outcomes_in_Ulcerative_Colitis_Patients/links/609c67ee4585158bf0a3d1f9/largepreview.png)
PDF) Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients
![Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis | Semantic Scholar Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b66be48c6957be0192ae051e8df4ca3cf8ebb7bd/3-Table2-1.png)
Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis | Semantic Scholar
La terapia biologica nelle IBD: Indicazioni attuali e prospettive future Università di Palermo Scuola di Specializzazione in G
![Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508522000786-gr2.jpg)
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect
![The Lancet Gastroenterology & Hepatology on Twitter: "Silvio Danese presents data from the U-ACHIEVE trial on the effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients The Lancet Gastroenterology & Hepatology on Twitter: "Silvio Danese presents data from the U-ACHIEVE trial on the effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients](https://pbs.twimg.com/media/FLz2Sg3VQAUcvKU.png)
The Lancet Gastroenterology & Hepatology on Twitter: "Silvio Danese presents data from the U-ACHIEVE trial on the effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients
![SciELO - Brasil - ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY SciELO - Brasil - ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY](https://minio.scielo.br/documentstore/1678-4219/Wcgr45ptmsycnjrvFFTswrm/e078a8261e0fc332c45b10a58b007032dc279cf5.jpg)